CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Open-market sale EVP, Europe Commercial sold 30,000 shares at $35.40 ($1,062,000)
- 144 Insider Sale of Securities
- 4 Open-market sale See "Remarks" sold 144,180 shares at $34.99 ($5,045,118)
- 4 Open-market sale EVP, U.S. Commercial sold 21,258 shares at $35.31 ($750,620)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale See "Remarks" sold 62,102 shares at $30.14 ($1,871,816)
- 144 Insider Sale of Securities
- 4 Option exercise See "Remarks" acquired 15,723 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 19,916 shares (option exercise)
- 4 Option exercise Chief Accounting Officer acquired 3,537 shares (option exercise)
- 4 Planned sale President and CEO sold 20,025 shares at $31.67 ($634,160)
- 4 Planned sale EVP, U.S. Commercial sold 7,924 shares at $31.67 ($250,940)
- 4 Planned sale See "Remarks" sold 9,533 shares at $31.67 ($301,895)
- 4 Planned sale EVP, Europe Commercial sold 17,295 shares at $31.67 ($547,705)
Page 5 of 128 · 2,555 filings